Published in Blood Weekly, February 2nd, 2012
"Two hundred fifty-eight consecutive treatment naive HCC patients who underwent RFA were enrolled. Patients aged <65 years (n=100) were defined as the younger group and those aged >65 years (n = 158) were the elderly group. Their clinicopathologic features and prognosis were compared. Younger patients had a higher...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.